DragonFire Transcatheter Myocardial Radiofrequency Ablation System

DEVICE2 trials

Sponsors

Hangzhou Valgen Medtech Co., Ltd

Conditions

Obstructive Hypertrophic Cardiomyopathy

Unknown Phase

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Active, not recruitingNCT06211595

Hangzhou Valgen Medtech Co., LtdObstructive Hypertrophic Cardiomyopathy

Start: 2022-10-13End: 2024-11-30Updated: 2024-01-18

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Not yet recruitingNCT06368037

Hangzhou Valgen Medtech Co., LtdObstructive Hypertrophic Cardiomyopathy

Start: 2024-08-31End: 2026-06-30Target: 10Updated: 2024-04-16